Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaush MeditechHKSE:02407 +0.61%67 Days Inventory is 156.59 as of Dec. 2025, which is 0% below its 10-year median of 157.19. GuruFocus rates HKSE:02407 with a GF Score™ of 67/100 and a GF Value™ of HK$13.39 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Gaush Meditech ranks better than 54.2% on this metric.
The historical rank and industry rank for Gaush Meditech's Days Inventory or its related term are showing as below:
HKSE:02407'
s Days Inventory Range Over the Past 10 Years
Min: 111.09 Med: 157.19 Max: 167.93
Current: 167.93
During the past 7 years, Gaush Meditech's highest Days Inventory was 167.93. The lowest was 111.09. And the median was 157.19.
HKSE:02407's Days Inventory is ranked better than 54.2% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs HKSE:02407: 167.93
Gaush Meditech's Days Inventory
increased
from Dec. 2024 (152.50) to Dec. 2025 (156.59).
It might indicate that Gaush Meditech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Gaush Meditech's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.17.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gaush Meditech's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.48.
Gaush Meditech (HKSE:02407) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Gaush Meditech's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gaush Meditech's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Gaush Meditech Days Inventory Related Terms
Gaush Meditech Days Inventory Historical Data
* Premium members only.
The historical data trend for Gaush Meditech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02407 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Gaush Meditech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaush Meditech Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Gaush Meditech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaush Meditech (HKSE:02407) has a Days Inventory of 156.59 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gaush Meditech and its competitors. This is near median its historical median of 157.19. Over the past decade, Gaush Meditech's Days Inventory has ranged from 111.09 to 167.93. According to the industry distribution chart, Gaush Meditech ranks #360 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 45.8%.
Is Gaush Meditech's Days Inventory too high?
Gaush Meditech's current Days Inventory of 156.59 is near median its 10-year median of 157.19. Over the past 10 years, this metric has ranged from a low of 111.09 to a high of 167.93. The Medical Devices & Instruments industry median Days Inventory is 179.60. Gaush Meditech's value of 156.59 is 12.8% below this industry median. Based on the distribution chart, Gaush Meditech ranks #360 out of 786 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Gaush Meditech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gaush Meditech's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Gaush Meditech ranks #360 out of 786 companies for Days Inventory. This puts Gaush Meditech in the upper half of its industry. The industry median Days Inventory is 179.60. Gaush Meditech's value of 156.59 is 12.8% below this benchmark. Historically, Gaush Meditech's own Days Inventory has ranged from 111.09 to 167.93 over the past decade. While the company's 10-year median is 157.19 vs. the industry median of 179.60, Gaush Meditech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaush Meditech's current Days Inventory of 156.59 is 12.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gaush Meditech and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaush Meditech's current Days Inventory is 156.59, which is near median its own 10-year median of 157.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaush Meditech stock overvalued right now?
Based on GuruFocus' analysis, Gaush Meditech (HKSE:02407) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.39, compared to a current price of HK$4.93 — trading 63.2% below its estimated fair value. The current Days Inventory is 156.59, which is near median its 10-year median of 157.19 and 12.8% below the Medical Devices & Instruments industry median of 179.60. Gaush Meditech's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Gaush Meditech (HKSE:02407), the current Days Inventory is 156.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gaush Meditech (HKSE:02407) Overvalued in 2026?
Based on GuruFocus' analysis, Gaush Meditech stock appears to be undervalued.
The current stock price of HK$4.93 is trading 63.2% below its estimated GF Value™ of HK$13.39.
GuruFocus considers Gaush Meditech to be Possible Value Trap.
Key valuation signals for HKSE:02407:
Days Inventory: 156.59 (near median its 10-year median of 157.19)
GF Value™: HK$13.39 vs. price of HK$4.93 (63.2% below fair value)
Industry Position: 12.8% below the Medical Devices & Instruments median (#360 of 786)
No single metric tells the full story. See the HKSE:02407 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
67GF Score
Get the complete analysis for HKSE:02407
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02407 has been successfully added to your 
